预测子痫前期不良母儿结局的研究进展

郑 越月¹, 任 春丽²
1、承德医学院河北承德
2、承德医学院附属医院产科

摘要

子痫前期影响母儿健康,是发生不良母儿结局的因素之一｡目前国内外有一些研究着眼于子痫前期孕产妇不良母儿结局的预测,但多集中于单一因素,而综合多因素建立的预测模型较少,且受样本量影响,其预测效果需校准｡本文旨在对预测子痫前期不良母儿结局的研究进展进行综述｡

关键词

子痫前期;不良母儿结局;预测

参考

[1]PoonLC,ShennanA,HyettJA,etal.TheInternationalFederationofGynecologyandObstetrics(FIGO)initiativeonpre-eclampsia:Apragmaticguideforfirst-trimesterscreeningandprevention[J].IntJGynaecolObstet,2019,146(3):390-391.[2]BrownMA,MageeLA,KennyLC,etal.Thehypertensivedisordersofpregnancy:ISSHPclassification,diagnosis&managementrecommendationsforinternationalpractice[J].PregnancyHypertens,2018,13(5):291-310.[3]温宇文,裘毓雯,周琳,等.高龄与非高龄孕妇子痫前期发病特征的荟萃分析[J].妇产与遗传,2018,8(1):15-22.[4]LiX,ZhangW,LinJ,etal.Pretermbirth,lowbirthweight,andsmallforgestationalageamongwomenwithpreeclampsia:Doesmaternalagematter?[J].PregnancyHypertens,2018,13(7):260-266.[5]WuLL,ChenYX,GuanXN,etal.[Associationsbetweenpre-pregnancybodymassindexandoccurrenceandclinicalfeaturesofpreeclampsia][J].ZhonghuaFuChanKeZaZhi,2021,56(2):96-101.[6]JeongDE,HyunSM,ChoI,etal.Theassociationbetweenmaternalpre-pregnancybodymassindexandpregnancyoutcomesofpreeclampsia[J].TaiwanJObstetGynecol,2022,61(3):441-446.[7]HastieR,BergmanL,WalkerSP,etal.AssociationsBetweenSolublefms-LikeTyrosineKinase-1andPlacentalGrowthFactorandDiseaseSeverityAmongWomenWithPretermEclampsiaandPreeclampsia[J/OL].JAmHeartAssoc,2022,11(16):e024395.https://pubmed.ncbi.nlm.nih.gov/35943054/.[8]VerlohrenS,BrenneckeSP,GalindoA,etal.ClinicalinterpretationandimplementationofthesFlt-1/PlGFratiointheprediction,diagnosisandmanagementofpreeclampsia[J].PregnancyHypertens,2022,27(12):42-50.[9]JeonHR,JeongDH,LeeJY,etal.sFlt-1/PlGFratioasapredictiveandprognosticmarkerforpreeclampsia[J].JObstetGynaecolRes,2021,47(7):2318-2323.[10]AntsaklisP,FasoulakisZ,TheodoraM,etal.AssociationofLowMaternalPregnancy-associatedPlasmaProteinAwithAdversePerinatalOutcome[J/OL].Cureus,2019,11(6):e4912.https://pubmed.ncbi.nlm.nih.gov/31423389/.[11]张颖,段红蕾,李洁.早孕期母血清PAPP-A水平与不良妊娠结局的相关性分析[J].中国优生与遗传杂志,2022,30(11):1972-1975.[12]KantomaaT,VääräsmäkiM,GisslerM,etal.Firsttrimesterlowmaternalserumpregnancyassociatedplasmaprotein-A(PAPP-A)asascreeningmethodforadversepregnancyoutcomes[J/OL].JPerinatMed,2022.https://pubmed.ncbi.nlm.nih.gov/36131518/.[13]KramerAW,Lamale-SmithLM,WinnVD.DifferentialexpressionofhumanplacentalPAPP-A2overgestationandinpreeclampsia[J].Placenta,2016,37(11):19-25.[14]KeikkalaE,ForsténJ,RitvosO,etal.SerumInhibin-AandPAPP-A2inthepredictionofpre-eclampsiaduringthefirstandsecondtrimestersinhigh-riskwomen[J].PregnancyHypertens,2021,25(5):116-122.[15]Leaños-MirandaA,Navarro-RomeroCS,Sillas-PardoLJ,etal.SolubleEndoglinAsaMarkerforPreeclampsia,ItsSeverity,andtheOccurrenceofAdverseOutcomes[J].Hypertension,2019,74(4):991-997.[16]IannacconeA,ReischB,MavaraniL,etal.SolubleendoglinversussFlt-1/PlGFratio:detectionofpreeclampsia,HELLPsyndrome,andFGRinahigh-riskcohort[J].HypertensPregnancy,2022,41(3-4):159-172.[17]GezerC,EkinA,ErtasIE,etal.Highfirst-trimesterneutrophil-to-lymphocyteandplateletto-lymphocyteratiosareindicatorsforearlydiagnosisofpreeclampsia[J].Ginekologiapolska,2016,87(6):431-435.[18]汪田田.母体外周血炎症指标水平与重度子痫前期的相关性研究[D].郑州大学,2021.[19]廖媛,刘兴会,谭婧,等.建立子痫前期不良结局风险预警模型的初步研究[J].四川大学学报(医学版),2018,49(05):797-802.[20]GuidaJP,CralcevC,CostaSantosJ,etal.ValidationofthefullPIERSmodelforpredictionofadverseoutcomesinpreeclampsiaatareferralcenter[J].PregnancyHypertens,2021,23(11):112-115.[21]UkahUV,PayneB,KarjalainenH,etal.TemporalandexternalvalidationofthefullPIERSmodelforthepredictionofadversematernaloutcomesinwomenwithpre-eclampsia[J].PregnancyHypertens,2019,15(1):42-50.[22]郑江元.子痫前期及其不良妊娠结局的预测模型构建[D].重庆医科大学,2022.